Additionally, those proteins not fully normalized by chronic insulin treatment in this study (Fgf2, Cp, Lgals3, Stat3, Cryba3, Crybb2) may be useful in testing novel therapeutics intended to be used in conjunction with insulin therapy to treat those dysregulations caused by diabetes that are not normalized by insulin replenishment. Here, FGF2 is linked to diabetes mellitus.